These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23740373)

  • 1. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.
    Pellegrino T; Petretta M; De Luca S; Paolillo S; Boemio A; Carotenuto R; Petretta MP; di Nuzzo C; Perrone-Filardi P; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1549-57. PubMed ID: 23740373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.
    Veltman CE; Boogers MJ; Meinardi JE; Al Younis I; Dibbets-Schneider P; Van der Wall EE; Bax JJ; Scholte AJ
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1599-608. PubMed ID: 22790878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study.
    Bellevre D; Manrique A; Legallois D; Bross S; Baavour R; Roth N; Blaire T; Desmonts C; Bailliez A; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1912-9. PubMed ID: 26227533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Cardiac
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.
    Leosco D; Parisi V; Pellegrino T; Pagano G; Femminella GD; Bevilacqua A; Paolillo S; Formisano R; Ferro G; de Lucia C; Prastaro M; Filardi PP; Cuocolo A; Rengo G; Ferrara N
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1601-11. PubMed ID: 25947572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
    Matsunari I; Aoki H; Nomura Y; Takeda N; Chen WP; Taki J; Nakajima K; Nekolla SG; Kinuya S; Kajinami K
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):595-603. PubMed ID: 20534790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of aging on cardiac sympathetic innervation measured by
    Rengo G; Pagano G; Vitale DF; Formisano R; Komici K; Petraglia L; Parisi V; Femminella GD; de Lucia C; Paolillo S; Cannavo A; Attena E; Pellegrino T; Dellegrottaglie S; Memmi A; Trimarco B; Cuocolo A; Filardi PP; Leosco D; Ferrara N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2392-2400. PubMed ID: 27287990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
    Iqbal B; Currie G; Kiat H
    J Med Imaging Radiat Sci; 2018 Dec; 49(4):397-405. PubMed ID: 30514557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.
    Dimitriu-Leen AC; Gimelli A; Al Younis I; Veltman CE; Verberne HJ; Wolterbeek R; Zandbergen-Harlaar S; Bax JJ; Scholte AJHA
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):326-332. PubMed ID: 26515715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality and utility of [
    Teresińska A; Woźniak O; Maciąg A; Wnuk J; Jezierski J; Fronczak A; Biernacka EK
    Ann Nucl Med; 2021 Aug; 35(8):916-926. PubMed ID: 34023989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
    Marshall A; Cheetham A; George RS; Mason M; Kelion AD
    Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the Heart-to-Mediastinum Ratio of
    Blaire T; Bailliez A; Ben Bouallegue F; Bellevre D; Agostini D; Manrique A
    J Nucl Med; 2018 Feb; 59(2):251-258. PubMed ID: 28646015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
    Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the
    Bateman TM; Ananthasubramaniam K; Berman DS; Gerson M; Gropler R; Henzlova M; Mendoza F; Miyamoto M; Shah M; Weiland F
    J Nucl Cardiol; 2019 Oct; 26(5):1555-1565. PubMed ID: 29344924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
    Dimitriu-Leen AC; Scholte AJ; Jacobson AF
    J Nucl Med; 2015 Jun; 56 Suppl 4():25S-30S. PubMed ID: 26033900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of
    Travin MI; Henzlova MJ; van Eck-Smit BLF; Jain D; Carrió I; Folks RD; Garcia EV; Jacobson AF; Verberne HJ
    J Nucl Cardiol; 2017 Apr; 24(2):377-391. PubMed ID: 26791866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.